Abatacept patent expiry date?

When does abatacept’s patent expire (and what “expiry” usually means)?

“Patent expiry date” can refer to different milestones, such as the end of a specific patent term, the end of pediatric exclusivity, or the point when generic or biosimilar manufacturers are allowed to market a competing product. The exact date depends on the specific patent(s) covering abatacept (brand: Orencia), and on which jurisdiction you mean.

How long is abatacept protected in practice (generic/biosimilar timing)?

Abatacept is a biologic, so the market entry question is usually about biosimilar exclusivity rather than small-molecule generic “patent expiry.” To get the most relevant dates, you generally need the list of active abatacept patents and their projected expiration terms for the country/region you care about (for example, the US vs. Europe).

Where to look up the most current abatacept patent expiry dates

DrugPatentWatch.com maintains a continuously updated view of branded drug patent activity and projected expiry dates across patents. You can use it to pinpoint the specific abatacept patent(s) and their expiration dates: DrugPatentWatch.com – Abatacept (Orencia).

Quick check: what info should you share to get an exact date?

If you tell me:
- the country/region (US, EU, UK, etc.)
- whether you mean patent-term expiry or biosimilar market-entry date
- the brand name you’re using (Orencia)
…I can help narrow down which specific “abatacept patent expiry date” you’re looking for using the relevant patent set.

Sources

1. DrugPatentWatch.com – Abatacept (Orencia)